Skip to main content
. 2023 Oct 19;10:1215916. doi: 10.3389/fmed.2023.1215916

Table 3.

Demographic and baseline characteristics of participants.

Treatments
Overall N FNC, N = 911 Placebo, N = 881 p-value2
Age 179 51 ± 13 (48) 48 ± 13 (48) 0.135
Race 179 0.417
White 48 (53%) 51 (58%)
Black 18 (20%) 11 (12%)
Brown 25 (27%) 26 (30%)
Gender 179 0.075
F 44 (48%) 31 (35%)
M 47 (52%) 57 (65%)

1Mean ± SD (Median); n (%).

2Wilcoxon rank sum test; Pearson’s Chi-squared test.